At first glance, this sweet Calico cat looks like the picture of calm, curled up beside her cat mom’s face, eyes half closed, completely content. She’s toothless, cozy, and clearly enjoying a quiet ...

In 2013, Google launched Calico Life Sciences to develop drugs for the treatment of ageing and age-related diseases. It was an ambitious plan, prompting Time magazine to ask on its cover ‘Can Google ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. AbbVie is cutting its ties with Calico Life Sciences and ...

AbbVie is ending an 11-year agreement with Alphabet’s Calico Labs, according to an internal email obtained by Stat. Now, the intensive project—which is focused on age-related diseases, including ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Calico launched the biotech ...

AbbVie (ABBV) is terminating a decade-long R&D collaboration with Calico Life Sciences, a company founded by Alphabet (GOOG) (GOOGL) to focus on age-related conditions, according to a report from Stat ...

Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s industry-leading events. AbbVie is ending a decade-long partnership with ...

A popular secondhand resale store has opened another shop in San Luis Obispo, and this one’s geared toward kids. Calico Kids, a children’s clothing resale boutique, opened Oct. 4 at 445 Madonna Road ...

Oct. 14 (UPI) --A rare calico lobster, bearing orange and black coloring believed to occur in only one in 30 million lobsters, was caught off Massachusetts and has a new home at a university.

This week, Kiara Bradford and Remington Miller explore the ghost town of East Calico Rock in Izard County and the mystery of the Gurdon Light in Clark County. Support journalism that digs deeper into ...

Calico Life Sciences announced on Thursday that the U.S. Food and Drug Administration (FDA) has issued Fast Track Designation for ABBV-CLS-628, a kidney disease therapy developed by the company in ...